Engaged Capital 13F holdings, Q1 2016
Holdings as of March 31, 2016 · filings on SEC EDGAR · latest filing →
Engaged Capital disclosed 12 US equity positions worth $296.3m in its Q1 2016 13F filing. The largest position was OUTERWALL INC at 30.4% of the reported book, followed by BHE and ROVI CORP. Against the Q4 2015 filing, it opened 2 new positions, added to 7 and reduced 0 among the top 12 holdings.
What did Engaged Capital own in Q1 2016? Top 12 positions
| # | Stock | Sector | Weight | Value | Shares | Δ shares | vs Q4 2015 |
|---|---|---|---|---|---|---|---|
| 1 | OUTERWALL INC | 30.4% | $89.9m | 2,431,170 | 919% | added | |
| 2 | BHE BENCHMARK ELECTRS INC | Technology | 18.9% | $56.0m | 2,428,221 | 188% | added |
| 3 | ROVI CORP | 15.6% | $46.1m | 2,250,000 | 0% | held | |
| 4 | JAMBA INC | 7.6% | $22.6m | 1,830,767 | 0% | held | |
| 5 | MED MEDIFAST INC | Consumer Cyclical | 7.5% | $22.3m | 737,465 | 0% | held |
| 6 | MX MAGNACHIP SEMICONDUCTOR CORP | Technology | 7.1% | $21.0m | 3,852,974 | 12% | added |
| 7 | TRS TRIMAS CORP | Consumer Cyclical | 4.0% | $11.9m | 679,067 | 7% | added |
| 8 | HEARTWARE INTL INC | 2.6% | $7.6m | 240,750 | 5% | added | |
| 9 | IWM ISHARES TR | 2.1% | $6.3m | 56,789 | – | new | |
| 10 | BIODELIVERY SCIENCES INTL IN | 2.0% | $6.1m | 1,876,550 | – | new | |
| 11 | LBYYQ LIBBEY INC | 1.7% | $5.0m | 270,064 | 76% | added | |
| 12 | AMAG AMAG PHARMACEUTICALS INC | 0.5% | $1.5m | 65,916 | 7% | added |
Weights are shares of the reported long US equity book (options excluded). Values are as filed, normalised to whole dollars. Share changes compare against the immediately preceding filing only.